Publication in New England Journal of Medicine: Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer

Zongli Zheng, post doc at MEB has, together with colleagues in the US, published a paper in the New England Journal of Medicine on non -small cell lung cancer.

Shaw AT, Ou SH, Bang YJ, et al. Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer. The New England journal of medicine 2014.